dc.contributor.author | Celikhisar, Hakan | |
dc.contributor.author | Tukek, Tufan | |
dc.contributor.author | Ucsular, Fatma Demirci | |
dc.contributor.author | Arman, Yucel | |
dc.contributor.author | Yalniz, Enver | |
dc.contributor.author | Ilkhan, Gulay Dasdemir | |
dc.date.accessioned | 2021-12-10T11:55:27Z | |
dc.date.available | 2021-12-10T11:55:27Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | Ilkhan G. D. , Ucsular F. D. , Celikhisar H., Arman Y., Yalniz E., Tukek T., "Can the endotrophin level in pulmonary fibrosis be a biomarker with differential diagnosis", SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, cilt.38, sa.2, 2021 | |
dc.identifier.issn | 1124-0490 | |
dc.identifier.other | av_9d701ac5-88a2-4475-8639-ae90828615ac | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/172904 | |
dc.identifier.uri | https://doi.org/10.36141/svdld.v38i2.10623 | |
dc.description.abstract | Aim: In this study, we aimed to investigate the possible role of endotrophin, a profibrotic byproduct of collagen VI, in the complex process of fibrosis development in the disease group with pulmonary fibrosis among interstitial lung diseases. | |
dc.language.iso | eng | |
dc.subject | Pulmonary and Respiratory Medicine | |
dc.subject | Health Sciences | |
dc.subject | Göğüs Hastalıkları ve Allerji | |
dc.subject | Respiratory Care | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | SOLUNUM SİSTEMİ | |
dc.title | Can the endotrophin level in pulmonary fibrosis be a biomarker with differential diagnosis | |
dc.type | Makale | |
dc.relation.journal | SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES | |
dc.contributor.department | Tire State Hospital , , | |
dc.identifier.volume | 38 | |
dc.identifier.issue | 2 | |
dc.contributor.firstauthorID | 2692086 | |